177 related articles for article (PubMed ID: 29984766)
1. Ovarian Metastases from ALK-rearranged Lung Adenocarcinoma: A Case Report and Literature Review.
Sasano H; Sekine A; Hirata T; Iwamoto K; Itou Y; Itani H; Kondou S; Tokui T; Tanigawa M
Intern Med; 2018 Nov; 57(22):3271-3275. PubMed ID: 29984766
[TBL] [Abstract][Full Text] [Related]
2. A Case of a Pregnant Woman Diagnosed as Having
Komura M; Yagishita S; Nakamura K; Arano N; Takeshige T; Muraki K; Nagashima O; Izumi H; Tomita S; Sasaki S; Takahashi K
In Vivo; 2018; 32(5):1205-1209. PubMed ID: 30150445
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma.
Koyama K; Katsurada N; Jimbo N; Tachihara M; Tamura D; Nakata K; Nagano T; Yamamoto M; Kamiryo H; Kobayashi K; Itoh T; Nishimura Y
Pathol Int; 2019 May; 69(5):294-299. PubMed ID: 30900377
[TBL] [Abstract][Full Text] [Related]
4. ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma.
Bi R; Bai Q; Zhu X; Tu X; Cai X; Jiang W; Xu X; Tang S; Ge H; Chang B; Cheng Y; Gan H; Zhou X; Yang W
Diagn Pathol; 2019 Aug; 14(1):96. PubMed ID: 31455365
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
Matsuura Y; Ninomiya H; Ichinose J; Nakao M; Okumura S; Nishio M; Mun M
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):441-451.e1. PubMed ID: 33131892
[TBL] [Abstract][Full Text] [Related]
6. ALK-positive adenocarcinoma of the lung expressing neuroendocrine markers and presenting as a "pituitary adenoma".
Mengoli MC; Bertolini F; Maur M; Barbieri F; Longo L; Gasparri P; Tiseo M; Rossi G
Pathologica; 2017 Dec; 109(4):408-411. PubMed ID: 29449735
[TBL] [Abstract][Full Text] [Related]
7. ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.
Mamesaya N; Nakashima K; Naito T; Nakajima T; Endo M; Takahashi T
BMC Cancer; 2017 Jul; 17(1):471. PubMed ID: 28683775
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.
Gupta R; Amanam I; Rahmanuddin S; Mambetsariev I; Wang Y; Huang C; Reckamp K; Vora L; Salgia R
Am J Clin Oncol; 2019 Apr; 42(4):337-344. PubMed ID: 30741758
[TBL] [Abstract][Full Text] [Related]
9. The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC).
Golding B; Luu A; Jones R; Viloria-Petit AM
Mol Cancer; 2018 Feb; 17(1):52. PubMed ID: 29455675
[TBL] [Abstract][Full Text] [Related]
10. Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement.
Fujiwara A; Higashiyama M; Kanou T; Tokunaga T; Okami J; Kodama K; Nishino K; Tomita Y; Okamoto I
Lung Cancer; 2014 Feb; 83(2):302-4. PubMed ID: 24360322
[TBL] [Abstract][Full Text] [Related]
11. Ovarian metastases from
Li H; Chen Y; Wang Y; Zhou L; Tian Z; Liu M; Li Y; Xu H; Wu W; Gong Z
Transl Cancer Res; 2022 Sep; 11(9):3391-3399. PubMed ID: 36237252
[TBL] [Abstract][Full Text] [Related]
12. ALK or ROS1-rearranged breast metastasis from lung adenocarcinoma: a report of 2 cases.
Wu X; Wang H; Fang M; Li C; Zeng Y; Wang K
Tumori; 2019 Dec; 105(6):NP67-NP71. PubMed ID: 31910790
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma.
He W; Xu D; Wang Z; Wu H; Xiang X; Tang B; Jiang W; Cui Y; Wang H; Jiang N; Sun Y; Chen Y; Li S; Hou M; Zhang Y; Wang L; Ke ZF
J Transl Med; 2019 Jan; 17(1):32. PubMed ID: 30658713
[TBL] [Abstract][Full Text] [Related]
14. Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America.
Arrieta O; Cardona AF; Bramuglia G; Cruz-Rico G; Corrales L; Martín C; Imaz-Olguín V; Castillo O; Cuello M; Rojas-Bilbao É; Casas G; Fernández C; Arén Frontera O; Denninghoff V; Recondo G; Avilés-Salas A; Mas-Lopez LA; Oblitas G; Rojas L; Piottante A; Jiménez-García E; Sánchez-Sosa S; Sáenz-Frias J; Lupera H; Ramírez-Tirado LA; Vargas C; Carranza H; Astudillo H; Wills LB; Pichelbaur E; Raez LE;
Oncology; 2019; 96(4):207-216. PubMed ID: 30476928
[TBL] [Abstract][Full Text] [Related]
15. Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel
Shimizu N; Akashi Y; Fujii T; Shiono H; Yane K; Kitahara T; Ohta Y; Kakudo K; Wakasa T
Anticancer Res; 2019 Jan; 39(1):413-420. PubMed ID: 30591488
[TBL] [Abstract][Full Text] [Related]
16. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
[TBL] [Abstract][Full Text] [Related]
17. Successful Drug Rechallenge Following Severe Acute Alectinib-induced Interstitial Lung Disease in a Patient With Advanced ALK-rearranged Lung Adenocarcinoma.
Gadotti LL; Nogueira Amorim Canedo FS; Ribeiro MFSA; Sacardo KP; Saddi R; Machado Alessi JV; de Abreu Testagrossa L; Katz A
Clin Lung Cancer; 2021 May; 22(3):e481-e486. PubMed ID: 32771343
[No Abstract] [Full Text] [Related]
18. Hemorrhagic Brain Metastases in a Patient with Anaplastic Lymphoma Kinase (ALK)-Rearranged Invasive Mucinous Adenocarcinoma of the Lung.
Shi M; Xu H; DiPoto Brahmbhatt A; Gonzalez-Toledo E; Georgescu MM
Am J Case Rep; 2018 Jan; 19():99-104. PubMed ID: 29371584
[TBL] [Abstract][Full Text] [Related]
19. Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.
Watanabe S; Hayashi H; Okamoto K; Fujiwara K; Hasegawa Y; Kaneda H; Tanaka K; Takeda M; Nakagawa K
Clin Lung Cancer; 2016 Nov; 17(6):528-534. PubMed ID: 27318655
[TBL] [Abstract][Full Text] [Related]
20. ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy.
Incharoen P; Reungwetwattana T; Saowapa S; Kamprerasart K; Pangpunyakulchai D; Arsa L; Jinawath A
World J Surg Oncol; 2016 May; 14():139. PubMed ID: 27142166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
